Chinese herbal medicine composition for preventing and treating thrombocytopenic purpura

Abstract

The present invention provides a Chinese herbal medicine composition for preventing and treating thrombocytopenic purpura. The Chinese herbal medicine composition is prepared from the following raw materials in parts by weight: 4-20 parts of a fructus corni extract, 2-15 parts of a saluia plebeia extract, 8-20 parts of a gynostemma pentaphyllum extract, 8-40 parts of a herba sarcandrae volatile oil extract, 8-35 parts of a radices lithospermi extract, 12-60 parts of triarrhena sacchariflora rhizome, 35-70 parts of a radix rubiae extract, 10-55 parts of a rhizoma corydalis decumbentis alkaloidextract, 2-30 parts of a persimmon leaf extract, 2-27 parts of a moellendorf's spikemoss herb biflavone extract, 2-15 parts of a hairyvein agrimony flavone extract and 2-25 parts of a leonurus alkaloid extract. The Chinese herbal medicine composition has a function of obviously increasing the number of platelets in peripheral blood, can be used for preventing and treating the thrombocytopenic purpura, enables the number of the platelets to reach a normal level, and is also simple in a preparation method and relatively low in cost.

Description

technical field [0001] The invention relates to the technical field of Chinese herbal medicines for preventing and treating thrombocytopenic purpura, in particular to a Chinese herbal medicine composition for preventing and treating thrombocytopenic purpura. Background technique [0002] Thrombocytopenic purpura is a hemorrhagic disease in which the skin and organs have a tendency to bleed and platelets are significantly reduced. Divided into primary or idiopathic thrombocytopenic purpura and secondary or symptomatic thrombocytopenic purpura. Clinically, the platelet count is lower than the normal range of 140,000-400,000 / μl. If not treated in time, it may easily lead to hemorrhagic anemia, and in severe cases, intracranial hemorrhage, hemorrhagic shock, and even life-threatening. [0003] At present, there is no specific western medicine for the treatment of thrombocytopenic purpura. Individualized treatment is required for different symptoms. Generally, glucocorticoids ar...

AI Technical Summary

Problems solved by technology

[0003] At present, there is no effective western medicine for the treatment of thrombocytopenic purpura. Individualized treatment is required for different symptoms. Generally, glucocorticoids are used for treatment. However, after the hormone is reduced or stopped, the platelets will decrease again. It has great side effects on the human body, such as central obesity, high blood pressure, diabetes, etc.

Severe patients can use large doses of gamma globulin. Other treatment methods, such as splenectomy and plasma exchange, can achieve a certain effect, but due to rapid consumption, high treatment costs, large side effects, and once the drug is stopped, the recurrence rate will decrease. higher

Images